Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:737-744
Published online before print July 25, 2005, doi: 10.1161/CIRCULATIONAHA.104.529248
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
112/5/737    most recent
CIRCULATIONAHA.104.529248v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dayal, S.
Right arrow Articles by Lentz, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dayal, S.
Right arrow Articles by Lentz, S. R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Animal models of human disease
Right arrow Brain Circulation and Metabolism
Right arrow Genetically altered mice

(Circulation. 2005;112:737-744.)
© 2005 American Heart Association, Inc.


Stroke

Cerebral Vascular Dysfunction in Methionine Synthase–Deficient Mice

Sanjana Dayal, PhD; Angela M. Devlin, PhD; Ryan B. McCaw, BS; Mei-Lan Liu, PhD; Erland Arning, PhD; Teodoro Bottiglieri, PhD; Barry Shane, PhD; Frank M. Faraci, PhD; Steven R. Lentz, MD, PhD

From the Departments of Internal Medicine (S.D., A.M.D., R.B.M., F.M.F., S.R.L.) and Pharmacology (F.M.F.), University of Iowa, Carver College of Medicine, Iowa City; Baylor Institute of Metabolic Disease, Dallas, Tex (E.A., T.B.); Department of Nutritional Sciences and Toxicology, University of California–Berkeley (M.-L.L., B.S.); and Veterans Affairs Medical Center, Iowa City, Iowa (S.R.L.).

Correspondence to Steven R. Lentz, MD, PhD, Department of Internal Medicine, C32 GH, University of Iowa, Iowa City, IA 52242. E-mail steven-lentz{at}uiowa.edu

Received December 12, 2004; revision received April 28, 2005; accepted May 6, 2005.

Background— Methionine synthase (MS) catalyzes the folate-dependent remethylation of homocysteine to methionine. We tested the hypothesis that deficiency of MS impairs endothelial function in mice heterozygous for disruption of the Mtr gene, which encodes MS.

Methods and Results— Plasma total homocysteine was similar in wild-type (Mtr+/+) and heterozygous (Mtr+/–) mice fed a control diet (4.5±0.3 and 5.3±0.4 µmol/L, respectively) and mildly elevated in Mtr+/+ and Mtr+/– mice fed a low-folate (LF) diet (7.5±0.7 and 9.6±1.2 µmol/L, respectively; P<0.001 versus control diet). Dilatation of cerebral arterioles to the endothelium-dependent dilator, acetylcholine (10 µmol/L) was blunted in Mtr+/– mice compared with Mtr+/+ mice fed the control diet (21±4 versus 32±4%; P<0.05). Both Mtr+/+ and Mtr+/– mice exhibited impaired dilatation of cerebral arterioles to acetylcholine when they were fed the LF diet (12±2 and 14±2%, respectively; P<0.01 versus Mtr+/+ mice fed the control diet). Elevated levels of superoxide and hydrogen peroxide were detected by confocal microscopy in cerebral arterioles of Mtr+/– mice fed the control diet and in both Mtr+/+ and Mtr+/– mice fed the LF diet.

Conclusions— These findings demonstrate that defective homocysteine remethylation caused by deficiency of either MS or folate produces oxidative stress and endothelial dysfunction in the cerebral microcirculation of mice.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. M. Devlin, R. Singh, R. E. Wade, S. M. Innis, T. Bottiglieri, and S. R. Lentz
Hypermethylation of Fads2 and Altered Hepatic Fatty Acid and Phospholipid Metabolism in Mice with Hyperhomocysteinemia
J. Biol. Chem., December 21, 2007; 282(51): 37082 - 37090.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Narayanasamy, B. Subramaniam, C. Karunakaran, P. Ranganathan, R. Sivaramakrishnan, T. Sharma, V. S. Badrinath, and J. Roy
Hyperhomocysteinemia and Low Methionine Stress Are Risk Factors for Central Retinal Venous Occlusion in an Indian Population
Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1441 - 1446.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. M. Colgan and R. C. Austin
Homocysteinylation of Metallothionein Impairs Intracellular Redox Homeostasis: The Enemy Within!
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 8 - 11.
[Full Text] [PDF]


Home page
BloodHome page
S. Dayal, K. M. Wilson, L. Leo, E. Arning, T. Bottiglieri, and S. R. Lentz
Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia
Blood, October 1, 2006; 108(7): 2237 - 2243.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. M. Faraci
Hydrogen peroxide: watery fuel for change in vascular biology.
Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 1931 - 1933.
[Full Text] [PDF]